Stable Glucagon for Treatment of Hyperinsulinism

Information

• Research Project
• 9567139

• ApplicationId

  9567139

• Core Project Number

  R43DK111304

• Full Project Number

  5R43DK111304-02

• Serial Number

  111304

• FOA Number

  PA-16-302

• Sub Project Id

• Project Start Date

  9/18/2017 - 7 years ago

• Project End Date

  8/31/2019 - 5 years ago

• Program Officer Name

  ARREAZA-RUBIN, GUILLERMO

• Budget Start Date

  9/1/2018 - 6 years ago

• Budget End Date

  8/31/2019 - 5 years ago

• Fiscal Year

  2018

• Support Year

  02

• Suffix

• Award Notice Date

  8/30/2018 - 6 years ago

Organizations

• AmideBio LLC

SUMMARY/ABSTRACT A series of glucagon analogues will be designed, produced at milligram levels, tested for solution stability and both in vitro and in vivo activity with the goal of providing a long term treatment for hyperinsulinism.

IC Name

• Activity

  R43

• Administering IC

  DK

• Application Type

  5

• Direct Cost Amount

• Indirect Cost Amount

• Total Cost

  207286

• Sub Project Total Cost

• ARRA Funded

  False

• CFDA Code

  847

• Ed Inst. Type

• Funding ICs

  NIDDK:207286\

• Funding Mechanism

  SBIR-STTR RPGs

• Study Section

  ZRG1

• Study Section Name

  Special Emphasis Panel

• Organization Name

  AMIDEBIO, LLC

• Organization Department

• Organization DUNS

  831649236

• Organization City

  BOULDER

• Organization State

  CO

• Organization Country

  UNITED STATES

• Organization Zip Code

  803043518

• Organization District

  UNITED STATES